The Missing Link Between AI Innovation And Manufacturing Execution

AI is the new buzzword across just about every industry and pharma is no exception. For leaders considering how best to integrate AI, automation, and digital initiatives onto the pharma manufacturing floor, the primary obstacle is maintaining compliance and control. Due to the delicate nature of these processes, sponsors leveraging digital transformation initiatives must support their effort with robust governance, orchestration, and security efforts.
Though the task may seem daunting, manufacturers that choose to be strategic and deliberate about when and where AI is allowed to operate will rapidly see the benefits of this technology. Industrial AI can be applied to analyze data, identify complex patterns, and propose solutions, however, it is not meant to make uncontrolled changes or replace human SMEs. Download the full Q&A article to gain expert insight into how better governance and orchestration can ensure that traceability is continuous and human oversight is built into AI processes.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.